56 related articles for article (PubMed ID: 38430420)
1. A Retrospective Real-World Study of Prognostic Factors Associated With EGFR Mutated Lung Cancer With Leptomeningeal Metastasis.
Wu Y; Zhao Y; Wu Y; Chen H; Ma S; Wang Q
Clin Lung Cancer; 2024 Jun; 25(4):347-353.e1. PubMed ID: 38418264
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.
Chiang CL; Yang HC; Luo YH; Chen CJ; Wu HM; Chen YM; Hu YS; Lin CJ; Chung WY; Shiau CY; Guo WY; Chou TY; Pan DH; Lee CC
J Neurosurg; 2023 Aug; 139(2):385-392. PubMed ID: 36681978
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intrathecal pemetrexed for TKI-failed leptomeningeal metastases from EGFR+ NSCLC: an expanded, single-arm, phase II clinical trial.
Fan C; Jiang Z; Teng C; Song X; Li L; Shen W; Jiang Q; Huang D; Lv Y; Du L; Wang G; Hu Y; Man S; Zhang Z; Gao N; Wang F; Shi T; Xin T
ESMO Open; 2024 Apr; 9(4):102384. PubMed ID: 38377785
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma with leptomeningeal metastases has been treated with comprehensive treatment for long-term survival: A case report and literature review.
Yang Y; Jiang J; Liu Y; Feng S; Bu H
Medicine (Baltimore); 2024 Jun; 103(23):e37853. PubMed ID: 38847717
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Metastases in IDH-wildtype Glioblastomas Revisited: Comprehensive Analysis of Incidence, Risk Factors, and Prognosis Based on Post-contrast FLAIR.
Park YW; Jang G; Kim SB; Choi K; Han K; Shin NY; Ahn SS; Chang JH; Kim SH; Lee SK; Jain R
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38822538
[TBL] [Abstract][Full Text] [Related]
6. Novel approaches to treatment of leptomeningeal metastases.
Primdahl D; Cohen-Nowak A; Kumthekar P
Curr Opin Neurol; 2023 Dec; 36(6):592-602. PubMed ID: 37865856
[TBL] [Abstract][Full Text] [Related]
7. Crucial differential diagnosis of rapidly progressive dementia: A case of leptomeningeal metastasis.
Mimura Y; Oi H; Takata T; Mimura M; Funayama M
PCN Rep; 2023 Sep; 2(3):e137. PubMed ID: 38867838
[TBL] [Abstract][Full Text] [Related]
8. Advances in targeted therapy in non-small cell lung cancer with actionable mutations and leptomeningeal metastasis.
Li D; Song Z; Dong B; Song W; Cheng C; Zhang Y; Zhang W
J Clin Pharm Ther; 2022 Jan; 47(1):24-32. PubMed ID: 34309914
[TBL] [Abstract][Full Text] [Related]
9. Next Generation Sequencing in the Management of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Literature Review.
Li S; Ke L; Meng X; Zhou H; Zhang X; Wu H; Yu J; Zhang H
Recent Pat Anticancer Drug Discov; 2021; 16(1):108-116. PubMed ID: 33245275
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of clinical and radiological factors on leptomeningeal metastasis from solid cancers.
Nakagawa K; Takano K; Nishino K; Ohe S; Nakayama T; Arita H
J Neurooncol; 2024 May; 167(3):397-406. PubMed ID: 38430420
[TBL] [Abstract][Full Text] [Related]
11. Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors.
Le Rhun E; Devos P; Weller J; Seystahl K; Mo F; Compter A; Berghoff AS; Jongen JLM; Wolpert F; Rudà R; Brandsma D; van den Bent M; Preusser M; Herrlinger U; Weller M
Neuro Oncol; 2021 Jul; 23(7):1100-1112. PubMed ID: 33367859
[TBL] [Abstract][Full Text] [Related]
12. Whole brain radiotherapy combined with intrathecal liposomal cytarabine for leptomeningeal metastasis-a safety analysis and validation of the EANO-ESMO classification.
Iglseder S; Nowosielski M; Bsteh G; Muigg A; Heugenhauser J; Mayer E; Grams A; Stockhammer G; Nevinny-Stickel M
Strahlenther Onkol; 2022 May; 198(5):475-483. PubMed ID: 35267049
[TBL] [Abstract][Full Text] [Related]
13. The clinical characteristic and prognostic factors of leptomeningeal metastasis in patients with non-small-cell lung cancer-a retrospective study from one single cancer institute.
Yan W; Jing W; An N; Tian Y; Guo D; Kong L; Zhu H; Yu J
Cancer Med; 2019 Jun; 8(6):2769-2776. PubMed ID: 30993909
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of Methods and Influencing Factors to Increase the Positive Rate of
Cytological Pathology of Cerebrospinal Fluid from Lung Cancer Leptomeningeal Metastases].
Gao N; Teng C; Fan C; Xin T
Zhongguo Fei Ai Za Zhi; 2022 Nov; 25(11):789-796. PubMed ID: 36419392
[TBL] [Abstract][Full Text] [Related]
15. Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Kuiper JL; Hendriks LE; van der Wekken AJ; de Langen AJ; Bahce I; Thunnissen E; Heideman DA; Berk Y; Buijs EJ; Speel EJ; Krouwels FH; Smit HJ; Groen HJ; Dingemans AM; Smit EF
Lung Cancer; 2015 Sep; 89(3):255-61. PubMed ID: 26117231
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
